Latest News

Do not use Kratom to fight opioid addiction, FDA warns

Recent times have seen the discussion revolve around the usage of Kratom. It is extracted from a plant that traditionally grows in the Southeast Asian region. When removed, it is sold in the market, usually in the form of capsules.

There is no denying in the intensity of the Opioid addiction. In fact, according to many experts, the USA is amidst its worst opioid crisis of the decade, causing the deaths of thousands of individuals in one single year.

To counter the worrisome situation, medical officials started recommending a list of possible alternatives to opioid. Shifting to medical marijuana for treatment of chronic pain was one viable solution which seemed to work successfully.

Another viable proposal put forward was using kratom containing drugs. It was believed that kratom helps fight addiction and the resulting withdrawal symptoms. People started buying the drugs in significant numbers until the Food and Drug Administration stepped into action.

After consultation and several examinations, FDA has disapproved of companies selling kratom containing drugs. These companies have been issued a final warning to curb their sales as soon as possible.

Kratom & Opioid Addiction

The two companies that have been most affected by the FDA ban are Call Botanicals and Kratom NC. Both had been in business for a considerably long time basing their operations selling kratom. Their products, promoted as the best available solution to the opioid addiction problem.

However, according to senior FDA commissioner, Dr. Sharpless, all the claims forwarded by the two companies are baseless. There is no empirical evidence to suggest that kratom drugs work in any situation.

More importantly, other associated risks need consideration. Firstly, most kratom products sold without following any essential guidelines. That is to say; physical examinations showed considerable contamination of salmonella. A salmonella is a form of bacteria that can lead to severe health complications such as intestinal infection.

Despite earlier warnings about the own risk of kratom, companies continued to indulge in transactions. While in no way scientific theory approves of kratom drugs in their ability to fight opioid addiction, on the contrary, the consequences are even more harmful to the person.

A Marketing Ploy?

Dr. Sharpless strongly believes that the promotion of Kratom drugs was nothing but a marketing ploy. The buyers realized that there was a demand in the market where opioid affected patients were looking for alternative therapies.

Particularly in the regions where the sale of medical marijuana remained restricted, there was an opportunity to sell kratom. In other circumstances, the drug was also sold illegally through the black market at a high price.

However, none of the claims about fighting the opioid addictions were ever validated by the FDA. Additionally, no research findings are available to augment an argument in favor of the medical benefits of kratom. Using it is, in fact, more consequential than it is beneficial.

A look at the statistics of Kratom related overdose fatalities shows us precisely that. Just about last year, around 90 deaths were reported across 30 different US states. The substance combined with heroin, which eventually cost the life of the individual.


Areeba Hussain

Areeba is an independent medical and healthcare writer. For the last three years, she is writing for Tophealthjournal. Her prime areas of interest are diseases, medicine, treatments, and alternative therapies. Twitter @Areeba94789300

Leave a Reply

Your email address will not be published. Required fields are marked *


Adblock Detected

Please consider supporting us by disabling your ad blocker